NEW YORK, July 19, 2021 / PRNewswire / – Partners of healthcare companies (âHEPâ), a healthcare private equity firm, is pleased to announce five achievements of existing portfolio companies and a new investment in Kno2, the tenth investment platform of HEP III. Following a tradition of supporting companies financed by founders, HEP’s investment was part of the first source of institutional capital raised by each of these six companies. âLess than two years ago, HEP invested in Twistle, which gave us more than just capital. They understand healthcare, have close relationships in the industry, and invest time to grow their portfolio companies. Partnering with them was one of the best decisions I’ve made. , and frankly, I would advise entrepreneurs to take a discount on the appraisal to get their investment, âsaid Kulmeet Singh, founder and CEO of Twistle.
Health Catalyst Announces Agreement to Acquire Twistle
June 24, Health Catalyst, Inc. (Health Catalyst) (NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced that it has entered into a definitive agreement for the ‘acquisition of Twistle, Inc. (“Twistle”), a Albuquerque, New MexicoHealthcare patient engagement SaaS technology company that automates patient-centric and HIPAA-compliant communication between healthcare teams and patients to transform the patient experience, improve care outcomes and reduce health costs.
âTwistle is a leading healthcare technology company committed to developing software that healthcare organizations and life science companies need to keep patients engaged in their healthcare. “, said Dan Burton, CEO of Health Catalyst. âTheir efforts to improve patient outcomes and reduce the cost of care are deeply aligned with our mission to be the catalyst for massive, measurable, and data-driven improvements. We are delighted to welcome the Twistle team to Health Catalyst and look forward to working together to enable healthcare organizations to deliver on the promise of people’s health. â
Health Enterprise Partners Completes Recapitalization of AllyAlign Health
At June 11, HEP announced that it has completed a significant recapitalization of its holding company AllyAlign Health (âAAHâ) by an investment syndicate led by New Enterprise Associates, Inc.
AllyAlign Health is a Medicare Advantage insurance company focused on improving the health and well-being of residents of senior housing communities. AAH strives to establish a retirement home healthcare ecosystem that creates better outcomes and a better experience for retirement home residents, retirement home communities, physicians and others. caregivers. HEP has partnered with Will saunders, CEO of AllyAlign Health, when the company was founded in 2014.
âHEP has been a great partner for AllyAlign Health and our team,â commented Will saunders, Founder and CEO of AllyAlign Health. âTheir insight, guidance and connections have been essential every step of the way. We look forward to significantly evolving our unique model in the ecosystem of skilled nursing and senior housing exiting the pandemic. “
Privia Health announces the closing of its initial public offering
At May 3, Privia Health Group, Inc. (Privia Health) (NASDAQ: PRVA), a technology-driven national physician empowerment company that works with medical groups, health plans and healthcare systems, announced the closing of its initial public offering of 22,425,000 ordinary shares at a public offering price of $ 23.00 per share. The offer consisted of 5,725,000 common shares offered by Privia Health and 16,700,000 common shares sold by the majority shareholder of Privia Health.
The number of shares offered and sold by Privia Health included the full exercise of the option of the underwriters to purchase up to an additional 2,925,000 common shares of Privia Health. The gross proceeds of the offering, before deduction of underwriting discounts and commissions and other expenses payable by Privia Health, were approximately $ 131.7 million. Privia Health will not receive any proceeds from the sale of the shares by its majority shareholder.
Shares of Privia Health began trading on the Nasdaq Global Select Market on April 29, 2021, under the ticker symbol “PRVA”.
Bank of America acquires AxiaMed
At April 2, Bank of America announced the acquisition of Axia Technologies, Inc. (âAxiaMedâ), a leading healthcare payments and technology company focused on facilitating secure patient payments.
“We are adding a talented team who bring great domain expertise and great technology, and we are delighted to have them join Bank of America,” said Marc Monaco, Head of Corporate Payments at Bank of America. âWe share a vision of providing customers with the best technology to meet their payment needs. By working together, we can leverage our common expertise and capabilities to provide a full range of payment and settlement solutions to our healthcare customers and their patients. “
SOC Telemed acquires Access Physicians
At March 30, SOC Telemed, Inc. (Nasdaq: TLMD), the leading national provider of acute care telemedicine solutions, announced that it has completed the acquisition of Access Physicians, an experienced provider of multi-specialty acute telemedicine, through a cash and stock purchase transaction valued at approximately $ 194 million, with additional potential performance-based consideration. By bringing together two market leaders, this combination strengthens SOC Telemed’s position as the nation’s largest acute care telemedicine service provider, backed by Telemed IQ, a purpose-built, scaled-up telemedicine platform. secure. Capable of serving as a single provider of acute care telemedicine solutions, the combined company now provides acute care telemedicine to nearly 1,000 facilities, including more than 700 hospitals, in 47 states.
In a rapidly growing acute care telemedicine market, this merger increases SOC Telemed’s national footprint, expands clinical service lines and broadens the breadth and depth of providers. Both companies share a mission to improve patient care through the combination of clinicians, technology and workflows. Together, SOC Telemed and Access Physicians are well positioned to meet the growing demand for acute telemedicine by leveraging their 27 years of combined experience.
HEP co-leads the investment in Kno2
At July 14th, Kno2Â®, the company that enables large-scale interoperability has announced that it has raised $ 15 million in a Series A round of funding to advance its goal of connecting all participants across the continuum of care, human or technological, for a secure, effortless and maximized exchange of patient information. The funding round was co-led by Partners of healthcare companies (HEP) and Providence companies.
The new funding will allow Kno2 to accelerate the continued expansion of connectivity and workflows on the platform while increasing the breadth and depth of the partner base built into the company’s APIs. It will also allow Kno2 to extend its reach to underserved markets such as small and medium-sized doctor’s offices, post-acute and behavioral care providers, community services, etc., by connecting these vital participants to the rest. of the health ecosystem.
About Health Enterprise Partners
Health Enterprise Partners provides expansion capital to innovative health services and health information technology companies. At the heart of HEP’s strategy is its unique and extensive hospital system and network of health plans, of which 36 members are investors in HEP ââfunds. HEP seeks to invest in companies that improve the quality of the patient experience, expand access, and lower the cost of healthcare.
This press release is for informational purposes only and is not intended to be investment advice or an offer or solicitation regarding the purchase of any investment. Investing with an investment firm is only suitable for qualified investors who fully understand the risks of such an investment. HEP is a registered investment adviser with the United States Securities and Exchange Commission. Registration does not imply a certain level of skill or training. Investments with HEP are only offered in accordance with applicable securities laws.
SOURCE healthcare company partners